Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.51 USD | -4.67% | -17.07% | -32.63% |
Mar. 11 | PaxMedica, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 19 | Certain Warrants of PaxMedica, Inc. are subject to a Lock-Up Agreement Ending on 19-FEB-2024. | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 3.78M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.47
x | P/E ratio 2025 * |
-
| Employees | 7 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 36.45% |
1 day | -4.67% | ||
1 week | -17.07% | ||
Current month | -19.05% | ||
1 month | -19.51% | ||
3 months | -35.30% | ||
6 months | -89.62% | ||
Current year | -32.63% |
Managers | Title | Age | Since |
---|---|---|---|
Howard Weisman
CEO | Chief Executive Officer | 65 | 20-03-03 |
Stephen Sheldon
DFI | Director of Finance/CFO | 44 | 22-06-30 |
David Hough
CTO | Chief Tech/Sci/R&D Officer | 67 | 23-08-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 22-09-30 | |
Howard Weisman
CEO | Chief Executive Officer | 65 | 20-03-03 |
Zachary Rome
BRD | Director/Board Member | 40 | 19-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.51 | -4.67% | 92,866 |
24-03-27 | 0.535 | +4.74% | 49,251 |
24-03-26 | 0.5108 | -11.01% | 144,874 |
24-03-25 | 0.574 | +4.02% | 49,831 |
24-03-22 | 0.5518 | -10.28% | 59,624 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.63% | 3.78M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |